» Articles » PMID: 2504481

Immunopathology of Schistosoma Mansoni Infection

Overview
Specialty Microbiology
Date 1989 Jul 1
PMID 2504481
Citations 74
Authors
Affiliations
Soon will be listed here.
Abstract

Schistosomiasis mansoni is a chronic helminthic disease that affects about 100 million people in the tropics. The worms have a life span of 5 to 10 years, and they live in the mesenteric veins of the host. Lightly infected individuals are asymptomatic or manifest mild intestinal symptoms. Heavily infected individuals often develop severe morbidity with hepatosplenomegaly, sometimes with a fatal outcome. Morbidity is attributed to the strong humoral and T-cell-mediated host immune responses developed to a variety of parasite antigens and expressed as tissue inflammations. The immunopathology includes dermatitis, immune complex-mediated kidney disease, and, chiefly, T-cell-mediated granuloma formation and fibrosis around disseminated parasite eggs. This review describes the mechanisms of induction and expression of immunopathology in infected persons and experimental animals. Immunoregulatory mechanisms that modulate the enhanced immune responses and may ameliorate excessive morbidity are discussed.

Citing Articles

The Roles of Various Immune Cell Populations in Immune Response against Helminths.

Lekki-Jozwiak J, Baska P Int J Mol Sci. 2024; 25(1).

PMID: 38203591 PMC: 10778651. DOI: 10.3390/ijms25010420.


Akkermansia muciniphila participates in the host protection against helminth-induced cardiac fibrosis via TLR2.

Wang J, Liu X, Sun R, Mao H, Liu M, Jin X PLoS Pathog. 2023; 19(10):e1011683.

PMID: 37788279 PMC: 10547169. DOI: 10.1371/journal.ppat.1011683.


Divide, conquer and reconstruct: How to solve the 3D structure of recalcitrant Micro-Exon Gene (MEG) protein from Schistosoma mansoni.

Nedvedova S, Guilliere F, Miele A, Cantrelle F, Dvorak J, Walker O PLoS One. 2023; 18(8):e0289444.

PMID: 37535563 PMC: 10399815. DOI: 10.1371/journal.pone.0289444.


Network Analysis and Nomogram in the Novel Classification and Prognosis Prediction of Advanced Schistosomiasis Japonica.

Liu X, Li Y, Ju S, Zhou Y, Qiang J Am J Trop Med Hyg. 2023; 108(3):569-577.

PMID: 36689944 PMC: 9978554. DOI: 10.4269/ajtmh.22-0267.


Docking-Based Virtual Screening Enables Prioritizing Protein Kinase Inhibitors With Phenotypic Activity Against Schistosoma mansoni.

Pereira Moreira B, Batista I, Tavares N, Armstrong T, Gava S, Torres G Front Cell Infect Microbiol. 2022; 12:913301.

PMID: 35865824 PMC: 9294739. DOI: 10.3389/fcimb.2022.913301.


References
1.
CHEEVER A, Dunn M, Dean D, Duvall R . Differences in hepatic fibrosis in ICR, C3H, and C57BL/6 mice infected with Schistosoma mansoni. Am J Trop Med Hyg. 1983; 32(6):1364-9. DOI: 10.4269/ajtmh.1983.32.1364. View

2.
Galvao-Castro B, Bina J, Prata A, Lambert P . Correlation of circulating immune complexes and complement breakdown products with the severity of the disease in human schistosomiasis mansoni. Am J Trop Med Hyg. 1981; 30(6):1238-46. DOI: 10.4269/ajtmh.1981.30.1238. View

3.
Deelder A, Kornelis D . Immunodiagnosis of recently acquired Schistosoma mansoni infection. A comparison of various immunological techniques. Trop Geogr Med. 1981; 33(1):36-41. View

4.
Walsh J . Veterans medical care: past, present and future. Bol Asoc Med P R. 1973; 65(1):1-6. View

5.
Sher A, McIntyre S, VON LICHTENBERG F . Schistosoma mansoni: kinetics and class specificity of hypergammaglobulinemia induced during murine infection. Exp Parasitol. 1977; 41(2):415-22. DOI: 10.1016/0014-4894(77)90114-x. View